Company intelligence / Profile preview

Regenity Biosciences

Paramus, New Jersey, United Statesregenity.com ↗
Ownership
Private
Employees
~275
Development stage
Commercial
01

Overview

Regenity has over 25 years of experience developing and commercializing bioresorbable implants for soft and hard tissue regeneration. Its portfolio includes more than 71 product lines, with several FDA-cleared devices such as RejuvaKnee™ for meniscal repair and DermiSphere hDRT for full-thickness wound healing. The company is a global leader in contract development/manufacturing of regenerative medical devices, supplying over four million units annually to clients in more than 86 countries.

Therapeutic areas
OtherNeurologyRheumatology
Modalities
Bioresorbable polymer implantCollagen-based deviceSynthetic polymer device
Industry
Implantable Medical Devices
02

Drug pipeline

1 asset

RejuvaKnee

Commercial
Indications
Meniscus repair
03

Partnerships

Fesarius Therapeutics Inc. – exclusive manufacturing/supply agreement for DermiSphere hDRT hydrogel deviceOEM/private label partnerships with various medtech companies (specifics undisclosed)

Beyond the preview

Go deeper on Regenity Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Regenity Biosciences.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call